Dry powder inhaler formulation of lipid–polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles-Reference-Cited by-同舟云学术

Dry powder inhaler formulation of lipid–polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles

Published:2012-09 Issue:1-2 Volume:434 Page:49-58
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Yang Yue,Cheow Wean Sin,Hadinoto Kunn

Funder

Ministry of Education of Singapore AcRF Tier I Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference20 articles.

1. Recent advances on chitosan-based micro- and nanoparticles in drug delivery;Agnihotri;J. Control. Release,2004

2. Evaluation of ultrasonic atomization as a new approach to prepare ionically cross-linked chitosan microparticles;Albertini;J. Pharm. Pharmacol.,2005

3. Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: a technical note;Bhumkar;AAPS PharmSciTech,2006

4. Salt effects on the interaction between adsorbed cationic polyelectrolyte layers: theory and experiment;Dahlgren;J. Phys. Chem.,1993

5. Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations;Donovan;Int. J. Pharm.,2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo pharmacodynamics of lactoferrin-coupled lipid nanocarriers for lung carcinoma: intravenous versus powder for inhalation;2023-10-17

2. Inhalable dry powder containing lipid polymer hybrid nanoparticles of Nintedanib esylate: In vitro and in vivo evaluations;Journal of Drug Delivery Science and Technology;2023-09

3. Green composites materials as a carrier for pulmonary drug delivery;Green Sustainable Process for Chemical and Environmental Engineering and Science;2023

4. Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments;Pharmaceutics;2022-12-31

5. Formulation Strategies to Improve the Stability and Handling of Oral Solid Dosage Forms of Highly Hygroscopic Pharmaceuticals and Nutraceuticals;Pharmaceutics;2022-09-22